Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.455 USD | +3.36% | -0.90% | +35.49% |
Mar. 20 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.49% | 338M | |
+2.15% | 42.75B | |
+47.70% | 41.61B | |
+12.03% | 41.34B | |
-12.36% | 26.59B | |
+8.04% | 25.49B | |
-23.73% | 18.12B | |
+30.13% | 12.24B | |
-1.95% | 11.76B | |
+8.10% | 11B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Tenaya Therapeutics Gets FDA Clearance For TN-401 Gene Therapy Trial